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Background: It hasn’t been clearly understood yet whether sensitization to antibiotics, the virus itself or transient
loss of drug tolerance due to the virus, is responsible for the development of maculopapular exanthems following
amoxicillin intake in patients with infectious mononucleosis. We aimed to examine whether sensitization to penicillin
developed among patients with skin rash following amoxicillin treatment within infectious mononucleosis.
Methods: Ten patients were investigated for drug sensitization by lymphocyte transformation test and six patients
were further tested by prick-, intradermal and patch tests employing the penicillin’s main antigens.
Results: Lymphocyte transformation test showed negative results with amoxicillin, while one patient had positive
reaction to cefixime. Six patients with suspected sensitization to amoxicillin were then investigated by in vivo tests.
Prick tests were negative in all six patients, but the intradermal tests showed positive reactions in four patients.
Conclusions: Our data demonstrate that in vitro testing is not sensitive enough in determining drug sensitization to
penicillin. In vivo tests should be performed to detect sensitization and indeed with skin tests our results confirmed
that sensitization to aminopenicillin may develop within infectious mononucleosis.
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Infectious mononucleosis (IM) is an acute disease
mostly caused by a widespread human γ-herpes virus,
the Epstein-Barr virus (EBV) or a human β-herpes virus,
the cytomegalovirus. The primary infection appears pre-
dominantly in children, adolescents and young adults [1].
Symptoms start with a prodromal phase including subfeb-
rility, malaise, arthralgia and myalgia, like any common
upper respiratory tract infection [2]. The classic features,
fever, tonsillopharyngitis, lymphadenopathy, leukocytosis
and hepatosplenomegaly, are helpful in differentiation
from bacterial infection. Skin eruptions may develop dur-
ing the infection. These eruptions are maculopapular
exanthems, morbilliform eruptions on the whole body,
in severe cases the progressive skin reaction turns into
erythroderma (Figure 1). A severe cutaneous reaction such
as erythema multiforme is exceedingly rare, although* Correspondence: onodikatinka@gmail.com
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unless otherwise stated.possible manifestation [3]. The skin symptoms may de-
velop due to the viral infection, however, these patients
often use antibiotics and it is also well-known that viral in-
fections enhance the risk of drug allergic reactions [4,5].
Eosinophil rich maculopapular exanthems occurring in
mononucleosis rash are considered to be delayed type
hypersensitivity reactions, in which Th2 T cells are acti-
vated and secrete IL-4, IL-5 and IL-13 that leads to eo-
sinophilic inflammation. However secretion of IgE and
IgG4 by B-cells accompanies the reaction, connecting
the delayed reaction to immediate type I reaction [6].
We aimed to examine whether sensitization to penicillin
developed among patients with cutaneous rash following
amoxicillin treatment within IM.Findings
Materials and methods
Patient selection
At the Department of Dermatology and Allergology,
University of Szeged in Hungary among those patients
who were treated between 2002 and 2012, ten youngntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Amoxicillin rash in a patient with infectious
mononucleosis (patient 4). The cutaneous eruptions developed a
few days after the initiation of the antibiotic therapy. In severe cases
the progressive maculopapular exanthems turn into erythroderma.
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35 years) with the diagnosis of IM, confirmed by EBV
serological assay (specific IgM and IgG antibodies), asso-
ciated with generalized maculopapular eruptions were
examined for sensitization to antibiotics. All of these pa-
tients underwent antibiotic therapy prior to the appear-
ance of skin eruptions. In all cases the antibiotic was
amoxicillin/clavulanic acid, in 2 cases in addition to
penicillin the patients were given clarithromycin or
cefixime as well. Although clinically the skin symptoms
of Drug Reaction with Eosinophilia and Systemic Symp-
toms (DRESS) can be indistinguishable, DRESS have
strict criteria, which were not met in our patients [7].
In vitro tests: lymphocyte transformation test (LTT)
We examined mononucleosis infectiosa patients with a
history of penicillin intake, with an in vitro method, the
LTT, 1–1.5 months after the cessation of skin eruptions.
The LTT was performed to determine T-cell prolifera-
tion as an indicator of drug sensitization as described
previously [8,9], with minor modifications. Briefly, per-
ipheral blood mononuclear cells were isolated from hep-
arinized peripheral blood and cultured under defined
conditions with various concentrations of the suspecteddrugs (100 μg/ml and 10 μg/ml dilutions), in our cases
with amoxicillin, amoxicillin/clavulanic acid, penicillin and
cefixime [10]. We evaluated cell growth in the cultures.
Cell growth was measured by using a colorimetric assay
and an automatic microplate scanning spectrophotometer.
The assay depends on the reduction of tetrazolium salt
(MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide) by living cells, to form a blue insoluble
formazan product [11]. During the investigation we
used the spontaneous cell growth as negative control,
while the phytohaemagglutinin-stimulated cell culture
served as positive control. The results were recognized
as positive, if the drug stimulated cell numbers were at
least twice higher that the negative control’s (stimula-
tion index >2).
In vivo test: skin tests
We performed in vivo cutaneous tests using penicillins in
patients with negative LTT to amoxicillin. The remaining
patients refused to consent to testing. Prick, intradermal
and patch tests were performed using penicillin’s main an-
tigens: major determinant benzylpenicilloyl poly-L-lysine
(PPL), minor determinant mix sodium benzylpenicillin,
benzylpenicilloic acid, sodium benzylpenicilloate (MDM)
from Diater Laboratorios (Penicillin allergenic determi-
nants (DAP) ® test) [12,13]. We followed the investigation
protocol given by the manufacturer [14]. Cutaneous tests
were started with major determinants (Figure 2). If the
prick tests at different dilutions were negative, the testing
was continued with intradermal and then patch tests. Each
prick and intradermal tests were read once 20 minutes
elapsed since their application. Tests results were also read
at 24, 48, 72 and 96 hours for detecting delayed reactions.
Patch tests were performed using the powdered culprit
drug mixed into vaseline (1:1). Allergens were applied to
the upper back in individual round chambers (Curatest®,
Spiromed Ltd.). Readings were performed at 48, 72,
96 hours and 7 days [15,16]. Although skin rashes occur-
ring in mononucleosis are likely delayed type reactions,
we performed immediate reading, because clinical history
cannot always be trusted, patients will report a delayed re-
action which is in fact an immediate one.
Results
Among those patients who were treated at our clinic be-
tween 2002 and 2012 10 patients (median age 22.9,
range 15–35 years) with IM and maculopapular rash
were examined by drug allergy tests. All patients took
antibiotics before the appearance of skin symptoms. In
all ten patients in vitro LTTs were performed with the
suspected drugs. Amoxicillin/clavulanic acid enhanced
drug-specific response in none of the cases. Increased
lymphocyte proliferation was found with one peripheral
blood sample after incubation with cefixime. Six out of
Figure 2 Positive cutaneous response (Penicillin allergenic
determinants (DAP) ® test). The in vivo cutaneous investigation
was continued with intradermal testing, if the prick tests resulted in
negative response at different dilutions. Skin tests were performed
using penicillin’s main antigens, major determinants and (PPL) and
minor determinant mix (MDM). Cutaneous tests were started with
major determinants, the negative control was saline solution. In this
case we recognized positive skin reaction to MDM at 1:100 and 1:10
dilutions, which verified the development of sensitization (patient 4).
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lin and negative LTT results were further investigated
in vivo by prick, intracutaneous and patch testing. All
six patients showed negative responses with prick tests.
The intradermal tests resulted in positive reactions in
four subjects. Patch tests were performed after negative
prick and intracutaneous testing with negative results in
the remaining two patients (Table 1).
It is important to notice that the in vivo investigations
were carried out at least six month after the disappear-
ance of the eruptions which lead us to think that drug
sensitization developed instead of a transient loss of tol-
erance, a transient Th-1 lymphocyte-mediated delayedTable 1 True sensitization to amoxicillin examined by in vivo
Patient Age(years) Gender Culprit drug LTT resu
1 15 female amoxicillin/clavulanic acid Negativ
2 19 female amoxicillin Negativ
3 29 female amoxicillin/clavulanic acid Negativ
4 23 male amoxicillin/clavulanic acid Negativ
5 35 male amoxicillin/clavulanic acid Negativ
6 24 female amoxicillin/clavulanic acid Negativ
7 21 male amoxicillin Negativ
8 20 female amoxicillin/clavulanic acid Negativ
9 16 male amoxicillin/clavulanic acid Negativ
10 27 male amoxicillin/clavulanic acid; cefixime Positive: ce
PPL: major determinant: benzylpenicilloyl poly-L-lysine.
MDM: minor determinant mix: sodium benzylpenicillin, benzylpenicilloic acid, sodium
Bold text: Verified sensitization to penicillin.
Tests were done in the following chronology: LTT→ Prick test (non-diluted PPL)→ Intra
(non-diluted MDM)→ Intradermal test (1:100 dilution of MDM, 1:10 dilution of MDM, nontype hypersensitivity reaction to the medication as dis-
cussed in the literature [17,18].
Discussion
The development of skin rash following amoxicillin intake
in patients with IM is quite frequent among beta-lactam-
induced adverse drug reactions [19]. These eruptions are
maculopapular exanthems. The exact mechanism behind
them is unclear. It is not well explained yet, whether a true
allergic drug reaction, virus-dependent rash or transient
loss of drug tolerance due to the virus is responsible for
the symptoms. The rash may be due to the viral infection
itself, the incidence of skin eruption development in acute
IM is 4.2-13% without drug intake, but often these pa-
tients are put on antibiotics, frequently amoxicillin, and
the rash appears a few days after the initiation of the anti-
biotic therapy [20]. Following amoxicillin intake within
acute IM the incidence of skin reactions ranges between
27.8% and 69%, while in children, morbilliform skin erup-
tions nearly always develop following amoxicillin intake
within acute IM [4,21,22].
Our aim was to find out whether true amoxicillin
sensitization developed for aminopenicillin among our pa-
tients. Evidence shows in recently published literature that
the development of allergic reaction for aminopenicillin
during a florid viral infection is definitely more prevalent
as it was believed previously [4,5]. Although Renn et al.
earlier demonstrated true sensitizations to amoxicillin in
three patients with IM and clear history of amoxicillin in-
take with positive proliferative responses, we further in-
vestigated this phenomenon to provide more evidence.
Our results add additional evidence that indeed in such
patients drug sensitization develops during the infection.
According to the current recommendations in drug
allergy, positive skin tests for beta-lactam antiobioticscutaneous tests
lts Prick testresults Intradermal test results
Patch test
results
e Negative PPL 1:100 and 1:10 Positive Not performed
e Negative MDM undiluted Positive Not performed
e Negative PPL 1:10 Positive Not performed
e Negative MDM 1:100 and 1:10 Positive Not performed
e Negative Negative Negative
e Negative Negative Negative
e Not performed Not performed Not performed
e Not performed Not performed Not performed
e Not performed Not performed Not performed
fixime Not performed Not performed Not performed
benzylpenicilloate.
dermal test (1:100 dilution of PPL, 1:10 dilution of PPL, non-diluted PPL)→ Prick test
-diluted MDM)→ Patch test (culprit drug).
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tests, to confirm clinical relevance. Skin tests are validated,
while LTT is not. We can not explain the negative results
of LTT in all of these cases to penicillins. The two patients
with negative in vitro and in vivo test results need to be
further investigated by performing cutaneous tests with
the culprit drug and if this was negative a drug provoca-
tion test should be applied in order to prove that the pa-
tient did not developed penicillin allergy. In this work our
primary aim was to demonstrate that true sensitization
can occur within mononucleosis infectiosa patients suffer-
ing from amoxicillin rash.
With this investigation we would like to further
emphasize the importance of allergy examination in pa-
tients with generalized skin lesions after penicillin intake
in IM, to verify whether true sensitization developed.
Conclusions
Our data demonstrate that in vitro testing is not sensi-
tive enough in determining drug sensitization for peni-
cillin in patients who develop skin symptoms during
mononucleosis infection. In vivo tests should be per-
formed to detect sensitization and indeed with skin tests
our results confirmed that sensitization to aminopenicil-
lin may develop within infectious mononucleosis.
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